Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Allergy & Immunology
•
Drug Allergy
Do you believe that pretreatment with montelukast or other LTRAs can reduce the risk of urticaria or angioedema with NSAIDS?
Related Questions
Are drug challenges after serum sickness-like reactions useful in delabeling the allergy?
Do you recommend desensitization to biologics since this has to occur repeatedly?
Do you prescribe fluocinolone in peanut oil in patients with peanut allergies?
Are you using any AI models to de-label penicillin allergy?
Is omalizumab an option for a patient needing a specific antibiotic with an IgE-mediated reaction who continues to have reactions during a desensitization?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
Do you utilize any desensitization protocols for delayed hypersensitivity reactions?
Do you perform patch testing with a history of SCAR with the goal of performing a drug challenge?
How do you manage an iodinated contrast allergy leading to grade 5 anaphylaxis in a patient who will foreseeably need another iodinated contrast agent in the future?
How often do you rely on using the C1 inhibitor functional assay versus quantitative level alone to diagnosis HAE?
